bf/NASDAQ:ARWR_icon.jpeg

NASDAQ:ARWR

Arrowhead Pharmaceuticals, Inc.

  • Stock

USD

Last Close

39.60

06/11 22:30

Market Cap

3.33B

Beta: 1.01

Volume Today

1.19M

Avg: 1.11M

PE Ratio

−16.68

PFCF: −12.05

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
Sep '24
net income
-91.94M
-
-81.72M
11.11%
-34.38M
57.93%
-54.45M
58.38%
67.97M
224.84%
-84.55M
224.39%
-140.85M
66.58%
-176.49M
25.31%
-209.28M
18.57%
-609.69M
191.34%
depreciation and amortization
2.34M
-
3.26M
39.54%
4.69M
43.88%
4.70M
0.19%
4.44M
5.54%
5.94M
33.86%
8.27M
39.12%
10.42M
26.06%
12.49M
19.88%
18.59M
48.84%
deferred income tax
-2.89M
-
2.35M
181.42%
-890.36K
137.86%
-432.14K
51.46%
-34.41M
-
stock based compensation
10.23M
-
11.60M
13.32%
7.89M
31.94%
8.45M
7.13%
12.39M
46.59%
43.38M
250.05%
76.67M
76.74%
120.89M
57.67%
78.13M
35.37%
73.97M
5.33%
change in working capital
3.41M
-
5.72M
67.80%
-1.21M
121.10%
-5.88M
387.04%
87.16M
1,582.85%
-60.69M
169.63%
226.87M
473.82%
-98.29M
143.33%
-51.55M
47.56%
25.09M
148.68%
accounts receivables
-75K
-
7.20K
109.60%
-259.58K
3,703.75%
-333.99K
28.66%
-184.31K
44.81%
-9.41M
5,004.93%
8.85M
194.01%
1.41M
84.06%
inventory
-1.89M
-
2.41M
227.48%
1.34M
44.64%
-1.26M
194.37%
1.60M
227.10%
9.16M
471.90%
-3.36M
-
accounts payables
2.50M
-
2.55M
2.28%
-3.51M
237.39%
-1.27M
63.81%
4.84M
481.28%
-821.01K
116.95%
2.63M
420.09%
-6.59M
350.72%
33.00M
600.80%
-5.54M
116.78%
other working capital
909.98K
-
5.13M
463.88%
-116.77K
102.28%
-5.68M
4,767.16%
83.91M
1,576.38%
-61.29M
173.04%
224.49M
466.29%
-100.55M
144.79%
-82.59M
17.86%
30.63M
137.08%
other non cash items
13.14M
-
-5.63M
142.83%
-43.52K
99.23%
383.07K
980.25%
1.07M
179.08%
525.30K
50.86%
266K
49.36%
7.34M
2,660.15%
50.72M
590.78%
29.19M
42.45%
net cash provided by operating activities
-65.71M
-
-64.43M
1.95%
-23.94M
62.84%
-47.22M
97.27%
173.03M
466.42%
-95.39M
155.13%
171.22M
279.50%
-136.13M
179.50%
-153.89M
13.05%
-462.85M
200.77%
investments in property plant and equipment
-1.97M
-
-3.86M
95.89%
-7.92M
105.12%
-1.42M
82.05%
-12.00M
744.41%
-11.95M
0.41%
-23.57M
97.19%
-52.78M
123.94%
-176.74M
234.88%
-141.47M
19.96%
acquisitions net
-10M
-
7.43B
-
47.75B
542.18%
240.78B
404.29%
141.68M
99.94%
-47.36M
133.43%
purchases of investments
-44.97M
-
-52.08M
15.81%
-90.27M
73.31%
-278.96M
209.05%
-240.70M
13.72%
-223.39M
7.19%
-246.14M
10.18%
-720.95M
192.90%
sales maturities of investments
26.09M
-
17.31M
33.66%
4.25M
75.45%
46.07M
984.31%
54.52M
18.35%
50.14M
8.04%
122.59M
144.51%
270.75M
120.86%
326.72M
20.67%
442.34M
35.39%
other investing activites
500
-
-7.43B
-
-47.75B
542.18%
-240.78B
404.29%
-141.68M
99.94%
47.36M
133.43%
net cash used for investing activites
14.12M
-
13.45M
4.77%
-48.64M
461.73%
-7.43M
84.72%
-47.75M
542.18%
-240.78M
404.29%
-141.68M
41.16%
-5.42M
96.18%
-96.16M
1,675.06%
-420.07M
336.87%
debt repayment
-213.99K
-
-217.55K
1.66%
-197.79K
9.08%
-208.51K
5.42%
-2.42M
1,058.31%
-250M
-
392M
256.80%
common stock issued
52.23M
-
12.42M
76.22%
56.59M
355.63%
60.52M
6.96%
250.48M
313.87%
11.30M
95.49%
5.19M
54.13%
3.05M
41.13%
429.26M
13,960.43%
common stock repurchased
dividends paid
other financing activites
504.51K
-
3.12M
518.01%
-166.02K
105.32%
3.58M
2,254.26%
8.28M
131.38%
7.47M
9.75%
60M
-
500M
733.33%
49.26M
90.15%
net cash used provided by financing activities
290.52K
-
55.13M
18,876.88%
12.06M
78.13%
59.95M
397.32%
66.38M
10.72%
257.95M
288.58%
11.30M
95.62%
65.19M
476.61%
253.05M
288.20%
870.52M
244.01%
effect of forex changes on cash
410K
-
-88K
121.46%
-67K
23.86%
-122K
82.09%
4.20M
3,540.16%
net change in cash
-51.30M
-
4.15M
108.09%
-60.53M
1,557.77%
5.29M
108.75%
191.67M
3,520.09%
-78.22M
140.81%
40.85M
152.22%
-76.43M
287.09%
2.89M
103.78%
-8.21M
384.34%
cash at beginning of period
132.51M
-
81.21M
38.71%
85.37M
5.11%
24.84M
70.90%
30.13M
21.32%
221.80M
636.08%
143.58M
35.27%
184.43M
28.45%
108.00M
41.44%
110.89M
2.67%
cash at end of period
81.21M
-
85.37M
5.11%
24.84M
70.90%
30.13M
21.32%
221.80M
636.08%
143.58M
35.27%
184.43M
28.45%
108.00M
41.44%
110.89M
2.67%
102.69M
7.40%
operating cash flow
-65.71M
-
-64.43M
1.95%
-23.94M
62.84%
-47.22M
97.27%
173.03M
466.42%
-95.39M
155.13%
171.22M
279.50%
-136.13M
179.50%
-153.89M
13.05%
-462.85M
200.77%
capital expenditure
-1.97M
-
-3.86M
95.89%
-7.92M
105.12%
-1.42M
82.05%
-12.00M
744.41%
-11.95M
0.41%
-23.57M
97.19%
-52.78M
123.94%
-176.74M
234.88%
-141.47M
19.96%
free cash flow
-67.68M
-
-68.29M
0.90%
-31.86M
53.35%
-48.64M
52.70%
161.03M
431.04%
-107.34M
166.66%
147.66M
237.56%
-188.91M
227.94%
-330.63M
75.02%
-604.32M
82.78%

All numbers in USD (except ratios and percentages)